Portal Vein Thrombosis (PVT) — A Complete Guide
By Dr. Chetan Kalal
Maharashtra's First DM Hepatologist | Liver Transplant & Cirrhosis Expert | Dedicated to Liver Health & Patient Education
What is Portal Vein Thrombosis (PVT)?
PVT refers to partial or complete obstruction of the portal vein by a thrombus (clot), impairing blood flow to the liver.
It is a common vascular complication in liver cirrhosis and also in non-cirrhotic conditions.
Why Does PVT Matter in Liver Disease?
"In cirrhosis, Portal Vein Thrombosis is both a marker of advanced disease and a therapeutic challenge."
— Dr. Chetan Kalal
Impact of PVT in Liver Patients:
Increases portal hypertension
Risk of variceal bleeding
Worsens liver decompensation
May complicate liver transplant surgery
Can cause intestinal ischemia (rare but life-threatening)
Causes of Portal Vein Thrombosis
| Cirrhotic Causes | Non-Cirrhotic Causes |
|---|---|
| Slow portal flow due to portal hypertension | Myeloproliferative disorders (JAK2 mutation) |
| Splenectomy or surgery | Inherited thrombophilia (Factor V Leiden, Protein C/S deficiency) |
| Hepatocellular carcinoma (HCC) invading portal vein | Inflammatory states (pancreatitis, intra-abdominal sepsis) |
| Dehydration, infection, variceal bleed | Oral contraceptive pills, pregnancy |
Clinical Presentation of PVT
Most patients are asymptomatic, especially in cirrhosis.
If Symptomatic:
Abdominal pain
Worsening ascites
Variceal bleeding
Intestinal angina
Intestinal infarction (if superior mesenteric vein involved)
Diagnosis of PVT
1. Doppler Ultrasound
→ First-line screening tool
2. Contrast CT or MRI
→ Confirm extent of thrombosis
→ Assess for collateral formation (cavernoma)
→ Rule out tumor thrombus (especially in HCC)
Classification of PVT
| Type | Extent of Thrombosis |
|---|---|
| Acute PVT | Sudden clot without cavernoma formation |
| Chronic PVT | Clot with portal cavernoma (collateral veins) |
| Non-Occlusive | Partial thrombosis |
| Occlusive | Complete blockage |
Management of Portal Vein Thrombosis
"Treatment should be individualized based on clot extent, symptoms, and transplant candidacy."
— Dr. Chetan Kalal
1. Anticoagulation Therapy
Low Molecular Weight Heparin (LMWH) initially
Long-term: Warfarin / DOAC (Apixaban, Rivaroxaban — in selected patients)
Goals:
Prevent clot extension
Achieve recanalization (best within 6 months of onset)
Prevent new thrombotic events
2. Non-Pharmacological Management
Treat underlying cirrhosis complications
Variceal bleed prophylaxis
Optimize nutrition
Avoid dehydration
3. Special Considerations
Liver Transplant Candidates
PVT does not exclude transplant
Preoperative anticoagulation recommended
Surgical or radiological thrombectomy may be needed
Non-Cirrhotic PVT
Work-up for hypercoagulable states is mandatory
Prognosis of PVT
Early detection + anticoagulation → 40-70% recanalization rates
Chronic PVT → Collateral formation protects against bowel ischemia
Advanced cirrhosis + PVT → Poorer outcomes
Dr. Chetan Kalal’s Message
"PVT reflects the dynamic nature of liver disease. Early detection through routine Doppler surveillance in cirrhosis saves lives. Anticoagulation therapy is safe when monitored well, even in advanced liver disease."
Keywords
Portal Vein Thrombosis in Cirrhosis
Dr. Chetan Kalal Liver Specialist Mumbai
Treatment of PVT in Liver Disease
Liver Transplant and Portal Vein Thrombosis
PVT Anticoagulation Protocol India
"Blood clots in the liver can block blood flow, worsen cirrhosis, and complicate transplant outcomes. Early Doppler check-up and proper treatment save lives. Consult Dr. Chetan Kalal — Maharashtra's First DM Hepatologist — for expert liver care."
#PortalVeinThrombosis #CirrhosisCare #LiverClotTreatment #DrChetanKalal #LiverTransplantExpert #HepatologyIndia
 — A Complete Guide){kind=link}